The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?

A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology ...

The MiniMed 780G system already has compatibility with Medtronic’s Guardian 4 and Simplera Sync sensors. Both offer up to seven days of wear. Now, with Instinct, users can more than double that sensor ...

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

The top 10 wearable medical devices include the Apple Watch, Fitbit health trackers, Samsung Galaxy Watch and the FreeStyle Libre range of glucose monitors Wearable devices are attached or embedded ...

Published in the Journal of Clinical Medicine, the study demonstrates that administering treatment of migraine with Remote Electrical Neuromodulation (REN) does not impact blood s ...

When you hear the word robotics, you probably think of factory machines or humanoid robots sprinting across a test track. That image makes sense. For years, robotics lived in labs and industrial ...

DexCom expects 2026 total revenue to be in a range of $5.16 billion to $5.25 billion, representing growth of 11% to 13% for the year. Sylvain indicated, "This guidance assumes continued strong ...